CFTC's Pham Said to Plot Exit, Agency May Be Left Without a Party Majority As Summer Mersinger exits to run the Blockchain Association and Caroline Pham talks of leaving when the new chairman ...

Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its ...